Alyeska Investment Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
Alyeska Investment Group's ALDR Position: Q4 2019 in Review
Alyeska Investment Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 880,173 shares — an estimated $16.6M sold.
Alyeska Investment Group first reported a position in ALDR in Q2 2014 and held it in 7 quarters. The position peaked at $16.6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Alyeska Investment Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Alyeska Investment Group sold 880,173 Alder Biopharmaceuticals shares in Q4 2019, an estimated $16.6M.
- Alyeska Investment Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 7 quarters.
- Alyeska Investment Group's Alder Biopharmaceuticals position peaked at $16.6M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.